In this article, we will discuss Ramucirumab (3). So, let’s get started. Premedication • Prior to each Ramucirumab infusion, premedicate all patients with an intravenous histamine H1 antagonist (e.g., diphenhydramine hydrochloride). • For patients who have experienced a Grade 1 or 2 infusion reaction, also premedicate with dexamethasone (or equivalent) and acetaminophen prior to each […]
Category: Ramucirumab
In this article, we will discuss Ramucirumab (2). So, let’s get started. Recommended Dose and Schedule • The recommended dose of Ramucirumab either as a single agent or in combination with weekly paclitaxel is 8 mg/kg every 2 weeks administered as an intravenous infusion over 60 minutes. Continue Ramucirumab until disease progression or unacceptable toxicity. […]
In this article, we will discuss Ramucirumab (1). So, let’s get started. Indications Gastric Cancer Ramucirumab as a single agent, or in combination with paclitaxel, is indicated for the treatment of patients with advanced or metastatic, gastric or gastro-esophageal junction adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy.
In this article we will discuss Ramucirumab (Mechanism of Action)